Published in Int Urogynecol J Pelvic Floor Dysfunct on December 03, 2005
Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress-predominant mixed incontinence. Int Urogynecol J (2012) 1.50
An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence. Int Urogynecol J (2010) 0.96
[The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc) (1995) 3.18
Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J Pelvic Floor Dysfunct (2004) 1.43
Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings. J Urol (2003) 1.21
Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol (1999) 1.15
Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol (1997) 1.14
Collagen injection therapy for urinary incontinence. Urol Clin North Am (1994) 0.85
[Validity of the King's Health questionnaire in the assessment of quality of life of patients with urinary incontinence. The King's Group]. Med Clin (Barc) (2000) 0.79
Complications of periurethral collagen injection for stress urinary incontinence. J Urol (1998) 0.78
Periurethral fat injection in the treatment of recurrent genuine stress incontinence. J Urol (1998) 0.76
Persistence of delayed hypersensitivity following transurethral collagen injection for recurrent urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2002) 0.75
Injection therapy for stress incontinence in women. Int Urogynecol J Pelvic Floor Dysfunct (1999) 0.75
Urinary retention and intravesical hemorrhage following urethral collagen injections in women using warfarin. Int Urogynecol J Pelvic Floor Dysfunct (2002) 0.75